510(k) K091522
K091522 is an FDA 510(k) premarket notification submitted by Immco Diagnostics, Inc. for the device "IMMULISA CELIAC G+ (GLIADIN) IGA AND IGG ANTIBODY ELISA". The FDA issued a decision of Substantially Equivalent on Feb 4, 2010. The device falls under product code MST (Antibodies, Gliadin), a Class II device regulated under 21 CFR 866.5750. Immco Diagnostics, Inc. has 54 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 4, 2010
- Date Received
- May 22, 2009
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antibodies, Gliadin
- Device Class
- Class II
- Regulation Number
- 866.5750
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Immco Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.